Home › Funds › Flagship Pioneering, LLC › MRNA
Flagship Pioneering, LLC position in MRNA
MODERNA INC · Health Care
Flagship Pioneering, LLC reported holding 4,632,149 shares of MRNA (MODERNA INC) in its Q2 2026 13F filing — a position valued at US$324.4M, representing 21.07% of its reported portfolio and ranking #2 among its reported holdings. Flagship Pioneering, LLC has disclosed MRNA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Flagship Pioneering, LLC's MRNA position evolved
Flagship Pioneering, LLC first disclosed a stake in MRNA in Q3 2023 at 9,666,038 shares (US$998.4M). The position peaked in Q1 2024 at 9,666,038 shares, worth US$1.03B. Across 12 filings, Flagship Pioneering, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 4,632,149 shares valued at US$324.4M. Notable position changes include a 52% trim in Q2 2024 (shares fell 44% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 9.67M | $998.41M | New |
| Q4 2023 | 9.67M | $961.29M | Hold |
| Q1 2024 | 9.67M | $1.03B | Hold |
| Q2 2024 | 4.63M | $550.07M | Reduce |
| Q3 2024 | 4.63M | $309.57M | Hold |
| Q4 2024 | 4.63M | $192.60M | Hold |
| Q1 2025 | 4.63M | $131.32M | Hold |
| Q2 2025 | 4.63M | $127.80M | Hold |
| Q3 2025 | 4.63M | $119.65M | Hold |
| Q4 2025 | 4.63M | $136.60M | Hold |
| Q1 2026 | 4.63M | $235.31M | Hold |
| Q2 2026 | 4.63M | $324.39M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRNA and 13F data
MRNA (MODERNA INC) is a Health Care company. 36 other funds we track also report a position in MRNA — the largest reported positions include Baillie Gifford & Co (US$1.28B), Theleme Partners LLP (US$564.3M), BANQUE PICTET & CIE SA (US$414.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRNA
- Baillie Gifford & Co 18.21M sh · $1.28B · Q2 2026
- Theleme Partners LLP 8.06M sh · $564.27M · Q2 2026
- BANQUE PICTET & CIE SA 2.15M sh · $414.27M · Q3 2026
- Douglas Lane & Associates, LLC 1.16M sh · $223.56M · Q3 2026
- Beau Ventures, LLc 1.00M sh · $192.58M · Q3 2026
- Merck & Co., Inc. 2.31M sh · $161.64M · Q2 2026
- Baron Funds 1.99M sh · $139.32M · Q2 2026
- BAMCO INC /NY/ 1.99M sh · $139.32M · Q2 2026
- IMC-Chicago, LLC 1.70M sh · $119.21M · Q2 2026
More on Flagship Pioneering, LLC
FAQ
How long has Flagship Pioneering, LLC held MRNA?
Flagship Pioneering, LLC has disclosed MRNA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Flagship Pioneering, LLC's current position in MRNA?
As of Q2 2026, Flagship Pioneering, LLC holds 4.63M shares of MRNA (MODERNA INC), valued at $324.39M, representing 21.07% of its reported portfolio and ranking #2.
Has Flagship Pioneering, LLC been buying or selling MRNA?
In the latest 13F filing (Q2 2026), Flagship Pioneering, LLC held unchanged its position in MRNA. The position peaked in Q1 2024 at 9.67M shares.
Which other funds hold MRNA?
Other major institutional holders of MRNA include Baillie Gifford & Co, Theleme Partners LLP, BANQUE PICTET & CIE SA, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.